The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma
- PMID: 27689459
- DOI: 10.3171/2016.7.JNS16396
The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma
Abstract
OBJECTIVE An increased extent of resection (EOR) has been shown to improve overall survival of patients with glioblastoma (GBM) but has the potential for causing a new postoperative neurological deficit. To investigate the impact of surgical neurological morbidity on survival, the authors performed a retrospective analysis of the clinical data from patients with GBM to quantify the impact of a new neurological deficit on the survival benefit achieved with an increased EOR. METHODS The data from all GBM patients who underwent resection at the University of Florida from 2010 to 2015 with postoperative imaging within 72 hours of surgery were included in the study. Retrospective analysis was performed on clinical outcomes and tumor volumes determined on postoperative and follow-up imaging examinations. RESULTS Overall, 115 patients met the inclusion criteria for the study. Tumor volume at the time of presentation was a median of 59 cm3 (enhanced on T1-weighted MRI scans). The mean EOR (± SD) was 94.2% ± 8.7% (range 59.9%-100%). Almost 30% of patients had a new postoperative neurological deficit, including motor weakness, sensory deficits, language difficulty, visual deficits, confusion, and ataxia. The neurological deficits had resolved in 41% of these patients on subsequent follow-up examinations. The median overall survival was 13.1 months (95% CI 10.9-15.2 months). Using a multipredictor Cox model, the authors observed that increased EOR was associated with improved survival except for patients with smaller tumor volumes (≤ 15 cm3). A residual volume of 2.5 cm3 or less predicted a favorable overall survival. Developing a postoperative neurological deficit significantly affected survival (9.2 months compared with 14.7 months, p = 0.02), even if the neurological deficit had resolved by the first follow-up. However, there was a trend of improved survival among patients with resolution of a neurological deficit by the first follow-up compared with patients with a permanent neurological deficit. Any survival benefit from achieving a 95% EOR was abrogated by the development of a new neurological deficit postoperatively. CONCLUSIONS Developing a new neurological deficit after resection of GBM is associated with a decrease in overall survival. A careful balance between EOR and neurological compromise needs to be taken into account to reduce the likelihood of neurological morbidity from surgery.
Keywords: EOR = extent of resection; GBM = glioblastoma; HR = hazard ratio; HRQOL = health-related quality of life; KPS = Karnofsky Performance Scale; RV = residual volume; extent of resection; glioblastoma; iMRI = intraoperative MRI; neurological deficit; oncology; postoperative morbidity; quality of life; resection.
Similar articles
-
Impact of removed tumor volume and location on patient outcome in glioblastoma.J Neurooncol. 2017 Oct;135(1):161-171. doi: 10.1007/s11060-017-2562-1. Epub 2017 Jul 6. J Neurooncol. 2017. PMID: 28685405
-
The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?J Neurosurg. 2016 Apr;124(4):977-88. doi: 10.3171/2015.5.JNS142087. Epub 2015 Oct 23. J Neurosurg. 2016. PMID: 26495941
-
Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.J Neurosurg. 2014 Nov;121(5):1115-23. doi: 10.3171/2014.7.JNS132449. Epub 2014 Sep 5. J Neurosurg. 2014. PMID: 25192475
-
Role of Intra-operative MRI (iMRI) in Improving Extent of Resection and Survival in Patients with Glioblastoma Multiforme.J Pak Med Assoc. 2017 Jul;67(7):1121-1123. J Pak Med Assoc. 2017. PMID: 28770902 Review.
-
Survival Benefit of Maximal Resection for Glioblastoma Reoperation in the Temozolomide Era: A Meta-Analysis.World Neurosurg. 2019 Jul;127:31-37. doi: 10.1016/j.wneu.2019.03.250. Epub 2019 Apr 1. World Neurosurg. 2019. PMID: 30947000 Review.
Cited by
-
Preoperative Stereotactic Radiosurgery for Glioblastoma.Biology (Basel). 2022 Jan 26;11(2):194. doi: 10.3390/biology11020194. Biology (Basel). 2022. PMID: 35205059 Free PMC article. Review.
-
An expanded role for surgery in grade 3 1p/19q co-deleted oligodendroglioma.Neurooncol Adv. 2023 Apr 21;5(1):vdad046. doi: 10.1093/noajnl/vdad046. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37215951 Free PMC article.
-
Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?J Neurooncol. 2021 Jul;153(3):537-545. doi: 10.1007/s11060-021-03794-8. Epub 2021 Jun 29. J Neurooncol. 2021. PMID: 34185258 Free PMC article.
-
Recent Advances in the Diagnosis and Treatment of Brain Tumors.Brain Sci. 2024 Feb 28;14(3):224. doi: 10.3390/brainsci14030224. Brain Sci. 2024. PMID: 38539613 Free PMC article.
-
A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma.J Neurooncol. 2020 Jul;148(3):419-431. doi: 10.1007/s11060-020-03556-y. Epub 2020 Jun 19. J Neurooncol. 2020. PMID: 32562247
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous